The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 30, 2025

Filed:

Jul. 14, 2017
Applicants:

Viracta Therapeutics, Inc., Cardiff, CA (US);

Nantkwest, Inc., Culver City, CA (US);

Inventors:

James N. Woody, Cardiff, CA (US);

Patrick Soon-Shiong, Culver City, CA (US);

Assignees:

Viracta Therapeutics, Inc., Cardiff, CA;

Nantkwest, Inc., Culver City, CA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/522 (2006.01); A61K 9/00 (2006.01); A61K 31/4709 (2006.01); A61K 31/506 (2006.01); A61K 38/15 (2006.01); A61K 38/17 (2006.01); A61K 39/00 (2006.01); A61K 39/395 (2006.01); A61K 40/11 (2025.01); A61K 40/31 (2025.01); A61K 40/46 (2025.01); A61K 45/06 (2006.01); A61P 31/22 (2006.01); A61P 35/00 (2006.01); A61P 35/04 (2006.01); C12N 9/80 (2006.01);
U.S. Cl.
CPC ...
A61K 31/522 (2013.01); A61K 9/0053 (2013.01); A61K 31/4709 (2013.01); A61K 31/506 (2013.01); A61K 38/15 (2013.01); A61K 38/177 (2013.01); A61K 38/1774 (2013.01); A61K 39/3955 (2013.01); A61K 39/39558 (2013.01); A61K 40/11 (2025.01); A61K 40/31 (2025.01); A61K 40/46 (2025.01); A61K 45/06 (2013.01); A61P 31/22 (2018.01); A61P 35/00 (2018.01); A61P 35/04 (2018.01); C12N 9/80 (2013.01); A61K 2039/505 (2013.01); A61K 2239/31 (2023.05); A61K 2239/38 (2023.05); A61K 2239/48 (2023.05); A61K 2239/51 (2023.05);
Abstract

Provided are methods and compositions for the treatment of cancer. The methods comprise administering to a subject an HDAC inhibitor and an immunotherapeutic agent. In certain instances the immunotherapeutic is an NK cell or a chimeric antigen receptor NK cell.


Find Patent Forward Citations

Loading…